Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Alkem Laboratories Ltd - 539523 - Corporate Action - Fixes Record Date For Payment Of Dividend And Cut-Off Date For Annual General Meeting

 The Board of Directors at its meeting held today i.e. 19th May, 2023, has, inter alia fixed 10th August, 2023 as the record date for the payment of final dividend and 18th August, 2023 as the Cut-off date for the purpose of the Annual General Meeting. The dividend, if declared by the shareholders, shall be paid on and from 30th August, 2023. Kindly take the same on record.
19-05-2023
Bigul

Alkem Laboratories Ltd - 539523 - Corporate Action-Board approves Dividend

 The Board of Directors at its meeting held today i.e. 19th May, 2023, has, inter alia: 1. recommended a final dividend of Rs. 10/- (Rupees Ten only) per equity share of Rs. 2/- each for the financial year ended 31st March, 2023, for the approval of the shareholders of the Company at the ensuing Annual General Meeting. 2. fixed that the 49th Annual General Meeting of the Company shall be held on 25th August, 2023 and the cut-off date for the purpose of the said Annual General Meeting has been fixed as 18th August, 2023. 3. fixed 10th August, 2023 as the record date for the purpose of payment of final dividend. The dividend, if declared by the shareholders, shall be paid on and from 30th August, 2023. The meeting of the Board of Directors of the Company commenced at 11.00 a.m. and concluded at 1.30 p.m. Kindly take the same on record.
19-05-2023
Bigul

Alkem Laboratories Ltd - 539523 - Results- Financial Results For Quarter And Year Ended March 31, 23

 In continuation of our letter dated 9th May, 2023 and pursuant to Regulation 30 read with Regulation 33 of the SEBI LODR Regulations, the Board of Directors of the Company, at its meeting held today, i.e. 19th May, 2023, has inter alia approved the Standalone and Consolidated Audited Financial Statements for the quarter and financial year ended 31st March, 2023. The Company hereby declares that the Auditors have expressed an unmodified opinion in the Audit Reports on Standalone and Consolidated Financial Results for the quarter and financial year ended 31st March, 2023. The meeting of the Board of Directors of the Company commenced at 11.00 A.M and concluded at 1.30 P.M.
19-05-2023
Bigul

Alkem Laboratories Ltd - 539523 - Board Meeting Outcome for Outcome Of Board Meeting Held On 19Th May, 2023

 The Board of Directors at its meeting held today i.e. 19/05/2023, has, inter alia: 1. approved the Standalone and Consolidated Audited Financial Statements of the Company for the quarter and FY ended 31/03/2023. 2. recommended a final dividend of Rs. 10/- per equity share of Rs. 2/- each for FY ended 31/03/2023, for the approval of the shareholders of the Company at the ensuing AGM. 3. fixed that the 49th AGM of the Company shall be held on 25/08/2023 and the cut-off date for the purpose of the said AGM has been fixed as 18/08/2023. 4. fixed 10/08/2023 as the record date for the purpose of payment of final dividend. The dividend, if declared by the shareholders, shall be paid on and from 30/08/2023. 5. Approved the alteration of AOA of the Company, subject to the approval of the shareholders at the ensuing AGM of the Company. The meeting of the Board of Directors of the Company commenced at 11.00 a.m. and concluded at 1.30 p.m.
19-05-2023
Bigul

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that a conference call to discuss the Q4FY23 and FY23 financial results will be held on Friday, 19th May, 2023 at 04.00 p.m. Please find attached herewith the conference call details. Kindly take note of the same.
09-05-2023
Bigul

Alkem Laboratories Ltd - 539523 - Board Meeting Intimation for Notice Of Meeting Of Board Of Directors Of The Company Scheduled To Be Held On 19Th May, 2023

 Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2023 ,inter alia, to consider and approve (i) the Standalone and Consolidated Audited Financial Results of the Company for the quarter and financial year ended 31st March, 2023; and (ii) to consider and recommend Final Dividend, if any, for financial year ended 31st March, 2023. Kindly take note of the same.
09-05-2023
Bigul

Alkem Laboratories Ltd - 539523 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

 Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyAlkem Laboratories Ltd 2CIN NO.L00305MH1973PLC174201 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY AA+ 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)CRISIL LTD. 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: MANISH NARANG Designation: President Legal Company Secretary and Compliance Officer EmailId: manishnarang@alkem.com Name of the Chief Financial Officer: RAJESH DUBEY Designation: President Finance and CFO EmailId: rajeshdubey@alkem.com Date: 25/04/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
25-04-2023
Bigul

Alkem Laboratories Ltd - 539523 - Compliances- Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended 31St March, 2023.

 In terms of Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Certificate received from Practising Company Secretary for the year ended 31st March, 2023. Kindly take the same on record.
12-04-2023
Bigul

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 This is to inform you that US FDA had conducted a GMP and Pre-Approval inspection at the Company's API manufacturing facility located at Ankleshwar, Gujarat from 03rd April, 2023 to 07th April, 2023. At the end of the inspection, no Form 483 was issued. Kindly take the same on record.
07-04-2023
Bigul

Alkem Laboratories Ltd - 539523 - Compliance Certificate For The Period Ended March, 2023

 With reference to the subject matter, please find enclosed herewith the Compliance Certificate under Regulation 7(3) SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, duly signed by the Compliance officer and the authorised representative of Link Intime India Pvt Ltd (RTA) for the year ended 31st March, 2023. Kindly take the same on your records.
06-04-2023
Next Page
Close

Let's Open Free Demat Account